Conference Mind welcomes all the researchers, scientists, scholars, professionals, engineers, exhibitors, sponsors, academic, scientific and university practitioners to attend and present their research activities virtually worldwide @ Biomedicine Global Meet 2021 during May 06-07, 2021.
Track 1. Biomedicine:
Biomedicine is theoretical medication and biomedicine is an academic discipline devoted to the development of human medicine, it explains health in phrases of biology. It attaches significance to studying about body structure (anatomy) and structures physiology, in specific to understanding mechanisms like the heart, arteries, nerves, brain and so on.
Track 2. Biomedical Science:
Biomedical science combines the fields of biology and medicine in order to focus on the health of both animals and humans. In biomedical science major, it covers the biochemical and physiological functions, anatomical and histological structures, epidemiology, and pharmacology. Majors in biomedical science are poised to make valuable contributions to the fields of both biology and medicine and many moves on to make discoveries in the field of biology that have important effects in the medical world.
Track 3. Pharmacotherapy:
Pharmacotherapy is the use of medicine in the treatment of diseases, conditions, and symptoms. Pharmacotherapy is not a contemporary science. The use of drugs to treat illness is a practice that has been accepted for thousands of years. The advantage to this method of pharmacotherapy is that the dose of medicine rendered is standardized and pure, rather than an unknown drug dosage administered in addition to a wide variety of other chemicals present in the
Tracks and Key Topics
- Track 3 : ghgfh
Organizing Committee Member
The annual growth rate of world biomedicine market has been outpacing that of the overall pharmaceutical market in recent years and this trend will continue in the coming years with a steady 10.4% growth per annum by 2020. In particular, China's biomedicine market is expected to grow at an even higher rate (15% annually) over the forecast 2015-2020 period, driven by increasing and aging population, government initiatives and favorable policies, improving level of biotech and innovation, and increasing urbanization as well as household income in China.
The global biopharmaceutical and biomedicine market were valued at US$ 358.4 Bn in 2016 and is expected to witness a CAGR of 9.4% over the forecast period (2017–2025). Cost of biopharmaceutical and biomedicine products are quite high as these need research and development process, and its manufacturing is very complex process, which needs highly skilled scientists. Such expensive biopharmaceutical products are not affordable to organizations in emerging economies such as India, China, and Africa. High cost of biopharmaceutical and biomedicine is a major factor hindering its adoption. For instance, in India a vial of Avastin, a monoclonal antibody, costs between US$ 372.65 to US$ 402.46.